1Huang Y,Wongamorntham S,Kasting J,et al.Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor mediated,angiotensin Ⅱ-independent mechanisms.Kidney Int,2006,69(1):105-113.
2Oliver JA.Receptor-mediated actions of renin and prorenin.Kidney Int,2006,69(1):105-113.
3Persson F,Rossing P,Schjoedt KJ,et al.Time course of the antiproteinuric and antihypertensive effects of directrenin inhibition in type 2 diabetes.Kidney Int,2008,doi:10.1038Pki.2008.68.
4Burgelova M,Kramer HJ,Teplan V,et al.Effects of angiotensin-(1-7)blockade on renal function in rats with enhanced intrarenal Ang Ⅱ activity.Kidney Int,2005,67(4):1453-1461.
5Liu Y.Renal fibrosis:new insights into the pathogenesis and therapeutics.Kidney Int,2006,69 (2):213-217.
6Ardaillou R,Tsagozis P,Karagouni E,et al.Antidiabetic mechanisms of angiotension converting enzyme inhibitors and angiotension Ⅱ receptor antagonists:beyond the rennin-angiontension system.J Am Soc Nephrol,2005,12(3):30-39.
8Yoshimoto T,Hirata Y.Aldosterone as a cardiovascular risk hormone.Endocr J,2007,54(3):359-370.
9Hayashida T,Decaestecker M,Schnaper HW.Cro ss talk between ERK MA P Kinase and Smad Signaling pathways enhances TGF-beta dependent responses in human mesangial cells.FA SEB J,2003,17(11):1576-1578.
10Yuan J,Jia R,Bao Y.Beneficial effects of spironolactoneon glomerular injury in streptozotocin-induced diabeticrats.J Renin Angiotensin Aldosterone Syst,2007,8(3):118-126.
2Holleberg NK.Aldosterone in the development and progression of renal injury.Kidney Int,2004,66:1-9.
3Ding G,van Goor H,Ricardo SD,et al.Oxidized LDL stimulates the expression of TGF-beta and fibronectin in human glomerular epithelial cells. Kidney Int, 1997,51 : 147-154.
4Ding G, Reddy K, Kapasi AA, et al. Angiotensin Ⅱ induces apoptosis in rat glomendar epithelial cells. Am J Physiol Renal, 2002,283 : F173 -FIB0.
5Blasi ER, Rocha R, Rudolph AE, et al. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.Kidney Int, 2003, 63: 1791-1800.
6Miric G, Dallemagne C, Endre Z, et al. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol, 2001,133: 687-694.
7Aldigier JC, Kanjanbuch T, Ma LJ, et al. Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol,2005, 16: 3306-3314.
8Lodha S, Dani D, Mehta R, et al. Angiotensin Ⅱ-Induced mesangial cell apoptosis: role of oxidative stress. Mol Med,2002, 8 : 830-840.
9Arima S, Kohagura K, Xu HL, et al. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol, 2003,14 : 2255-2263.
10Glorioso N, Filigheddu F, Parpaglia PP, et al. 11 beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. Eur Heart J, 2005,26: 498-504.
3Lee KU, Harris RA. Mitochondria and Endoplasmic Reticulum in Diabetes and Its Complications. Experimental Diabetes Re- search, 2012. 2012.
4Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicology and Ap- plied Pharmacology, 2006,212(2) : 167 - 178.
5Hara K. A genetic variation in the PGC - 1 gene could confer in- sulin resistance and susceptibility to Type 11 diabetes. Diabeto- logia ,2002,45 ( 5 ) : 740 - 743.
6Hickey FB. IHG - 1 Promotes Mitochondrial Biogenesis by Sta- bilizing PGC - 1 ct. Journal of the American Society of Nephrolo- gy, 2011,22(8) :1475 - 1485.
7Knutti D, Kralli A. PGC - 1, a versatile coactivator. Trends in Endocrinology & Metabolism, 2001,12 ( 8 ) :360 - 365.
8Rasbach KA, Schnellmann RG. Signaling of rnitochondrial bio- genesis following oxidant injury. Journal of Biological Chemistry, 2007,282 (4) :2355 - 2362.
9Valle L. PGC - l alpha regulates the mitochondrial antioxidant defense system in vascular endothelial ceils. Cardiovasc Res, 2005,66 ( 3 ) : 562 - 573.
